CRP and COVID-19: Remarkably, our study highlights SFC’s potential to outperform other biomarkers in predicting negative outcomes in COVID-19, which is further supported by parallel findings in other acute illnesses, such as community-acquired pneumonia, where SFC was similarly found to surpass CRP and procalcitonin in prognostic accuracy [27].